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ABSTRACT
Background: In children, exhaled nitric oxide (eNO) is usually confounded by factors such as age and height.
We evaluated the relationship between eNO and lung function by minimizing the effects of aging and height.
Methods: In Study 1, the subjects comprised 738 elementary school children and junior high school children
(aged 6 to 15 years, 366 males and 372 females). They were divided into two groups according to age (6-10
years and 11-15 years). A height range was determined by a histogram of height in each group. In Study 2,
lung function, respiratory resistance and eNO level were measured in age- and height-limited groups.
Results: In Study 1, total of 148 younger children ranging in height from 120 to 130 cm and 180 older children
ranging in height from 148 to 158 cm participated in Study 2. The level of eNO among asthmatic children was
higher than that of normal children in both the younger and the older groups. The decrease in forced expiratory
volume in 1 second (FEV1) and other parameters of central airway resistance did not correlate with the eNO
level. However, the small airway parameters of MMEF and 25HT in older asthmatic children, and 25HT
and R5-R20 in younger asthmatic children inversely correlated with eNO.
Conclusions: Our data suggest that eNO level inversely correlates with small airway narrowing, and airway
inflammation has a significant effect on small airway lung function in asthmatic school children.
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INTRODUCTION
The measurement of exhaled nitric oxide (eNO) has
been proposed as a non-invasive marker of airway in-
flammation in asthmatic patients.1-4 The eNO is use-
ful for diagnosing childhood asthma as well as for
predicting asthma relapse in children with clinical
asthma remission.5-7 Recent studies have demon-
strated that eNO levels are decreased by anti-
inflammatory treatment,8 and the measurement of
eNO has been proposed as a method of monitoring
the efficacy of treatment in asthmatic patients.9
However, previous research concerning the effect
of acute airway narrowing on eNO level, reported a
rapid reduction in the eNO level after methacholine
challenge,10,11 and this reduction did not correlate
with the decrease in forced expiratory volume in 1
second (FEV1). In addition, several authors reported
that eNO values increase following β2-agonist ther-
apy.12,13 Despite the large number of studies of eNO
in children, the relationship between lung functions
and eNO levels has remained unclear because meas-
urements are often confounded by factors such as
age and height, which have a potent effect on eNO
level.
In the present study, we sought to evaluate
whether the eNO level in normal and asthmatic chil-
dren correlates with lung function and respiratory re-
sistance in large and small airway passeges measured
by the impulse oscillometry system. Because it is well
known that age and height have a remarkable effect
on eNO levels in children,14-16 we strictly limited
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Fig.　1　Histogram of Two Groups in Study 1. a: In the younger children (6-10 years), the mean height ± SD was 124.5 ± 
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these factors in the study participants.
METHODS
SUBJECTS
In 2007 and 2008, we performed a health check using
questionnaires and lung function tests in 738 children
from 2 elementary schools and one junior high
school in Maebashi City, Gunma Prefecture, Japan.
To control for the effect of age and height, the chil-
dren were categorized according to height ranges de-
termined by a histogram of height.
To diagnose asthma, the parents of each child com-
pleted an ATSDLD respiratory questionnaire in
Japanese. If the child had experienced more than 3
episodes of wheezing and was diagnosed asthma by a
physician, the child was determined to be asthmatic.
All of the asthmatic children were well controlled,
and participated in the school curriculum. Further-
more, none of the study subjects regularly used in-
haled steroids, inhaled long-acting beta agonists and
oral steroids, but an asthmatic subject in the older
group used pranlukast, leukotriene antagonist. Ap-
proval was obtained from the Gunma University Hos-
pital Ethics Committee, and informed parental con-
sent for each child was obtained before the study.
STUDY DESIGN
In Study 1, the parents of students in 2 elementary
schools and one junior high school were asked to
complete a questionnaire regarding their child’s his-
tory of wheezing and respiratory diseases. At 15:00-
18:00 from September to November in 2007 and 2008,
lung function, airway resistance and eNO were meas-
ured at each school. The eNO level was measured
prior to the evaluation of lung function and respira-
tory resistance.
The height and weight of each subject were meas-
ured by school teachers within one week before the
study. The height range categories for Study 2 were
determined by a histogram of height using data from
Study 1.
OFF-LINE eNO COLLECTION AND ANALYSIS
The off-line eNO measurements were performed us-
ing a standardized device (Sievers Instruments, Boul-
der, CO, USA) as well as a modified device (Fig. 1).17
In order to monitor the oral pressure and the flow vol-
ume, we modified the standardized device and at-
tached a flowmeter with a manometer. A plastic tube
(internal diameter 3 mm and length 23 cm) was con-
nected to a valve and worked as a flow restrictor. Us-
ing this modified device, the subjects exhaled
through resistance, and maintained a constant pres-
sure of 20-22 cmH2O, which led to a constant flow of
50 mls. Using the standardized device, the subjects
exhaled against a constant pressure of 20-22 cmH2O,
which led to a constant flow of 100 mls. All partici-
pants inspired NO-free medical air and performed
one single exhalation into a NO-inert and imperme-
able 1.5-L Mylar balloon. Because the on-line eNO
reaches a plateau 5 seconds after the beginning of ex-
halation in both adults and children,17 we instructed
the subjects to continue exhaling for 10 seconds. Af-
ter 5 seconds of exhalation, the operator attached the
Mylar balloon to the plastic tube and collected the
sample for the last 5 seconds. The sample was meas-
eNO and Childhood Asthma
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Table　1　Profi les of Patients
No. m : f Age (years) Height (cm) Weight (kg) eNO (ppb)
Study 1
 6-10 years 246 126 : 120  8.5 ± 1.1 124.9 ± 8.2 27.6 ± 7.2 30.2 ± 18.4
11-15 years 492 240 : 252 12.7 ± 1.3  152.6 ± 10.0  45.6 ± 11.5 34.8 ± 28.3
Study 2
120-130 cm
Total 148 70 : 78  8.5 ± 0.9 125.6 ± 3.3 24.7 ± 1.6 30.9 ± 18.3
Normal 114 53 : 61  8.5 ± 0.9 125.6 ± 3.3 24.6 ± 1.7 27.1 ± 14.3
Asthma 34 17 : 17  8.4 ± 0.9 125.9 ± 3.2 27.4 ± 4.5  43.4 ± 24.1*
148-158 cm
Total 180 119 : 61 12.9 ± 1.2 154.2 ± 3.0 48.2 ± 8.5 31.9 ± 27.1
Normal 133 85 : 48 13.1 ± 1.2 154.5 ± 2.5 48.7 ± 8.2 28.4 ± 20.0
Asthma 47 29 : 18 13.0 ± 1.1 151.8 ± 3.2 44.9 ± 8.5  40.5 ± 36.2*
*p < 0.01 compared with normal subjects.





V25/HT R5 R5-R20 X5
Study 1
 6-10 years 1.74 ± 0.4 1.56 ± 0.3 1.97 ± 0.5 2.23 ± 0.6 0.85 ± 0.3 0.71 ± 0.2 0.18 ± 0.1 -0.25 ± 0.1
11-15 years 2.83 ± 0.8 2.53 ± 0.7 3.03 ± 1.0 3.40 ± 1.2 1.14 ± 0.4 0.45 ± 0.1 0.08 ± 0.1 -0.15 ± 0.1
Study 2
120-130 cm
Total 1.69 ± 0.3 1.51 ± 0.2 1.88 ± 0.4 2.13 ± 0.5 0.81 ± 0.2 0.74 ± 0.2 0.18 ± 0.1 -0.25 ± 0.1
Normal 1.69 ± 0.3 1.52 ± 0.2 1.90 ± 0.4 2.14 ± 0.5 0.83 ± 0.2 0.73 ± 0.2 0.18 ± 0.1 -0.25 ± 0.1
Asthma 1.69 ± 0.2 1.49 ± 0.2 1.80 ± 0.5 2.08 ± 0.5 0.75 ± 0.2 0.74 ± 0.2 0.19 ± 0.1 -0.25 ± 0.1
148-158 cm
Total 2.92 ± 0.5 2.58 ± 0.4 3.03 ± 0.7 3.34 ± 0.8 1.17 ± 0.4 0.41 ± 0.1 0.05 ± 0.1 -0.13 ± 0.1
Normal 2.93 ± 0.5 2.60 ± 0.4 3.14 ± 0.8 3.45 ± 0.9 1.22 ± 0.4 0.40 ± 0.1 0.05 ± 0.1 -0.13 ± 0.1
Asthma 2.77 ± 0.4  2.41 ± 0.3* 2.70 ± 0.7** 2.99 ± 0.8** 1.01 ± 0.3** 0.43 ± 0.1  0.07 ± 0.1* -0.14 ± 0.1
*p < 0.05, **p < 0.01 compared with normal subjects.
ured by an NO analyzer (model 280i metric oxide
analyzer; Sievers Instruments) within 3 hours after
collection. In this study, we used new balloons for
measurement, and discarded them after 5 or 6 times.
PULMONARY FUNCTION TESTS
Pulmonary function was determined by spirometry
with a calibrated computerized pneumotachograph
spirometer (Jaeger Masterscope PC; Hoechberg,
Germany; LAB Manager Software version 4.53.2,
2002). Standard measures of pulmonary function
were collected, including FVC, FEV1, and 50, 25
HT. The procedure for all pulmonary function tests
involved the following pattern; (1) three normal tidal
volume breaths, (2) inhalation to total lung capacity,
(3) forced maximal exhalation, and (4) a final maxi-
mal inhalation. All tests were performed according to
the current American Thoracic Society spirometry
standards. The resting baseline was selected using
the best-of-three resting results based on the highest
sum of FVC and FEV1. One maneuver was performed
at each post-challenge time point in an effort to mini-
mize subject fatigue and guard against the potential
effects of deep inhalation. However, if any baseline or
post-challenge time point measurement was techni-
cally unacceptable, the maneuver was repeated im-
mediately.
IMPULSE OSCILLOMETRY SYSTEM
Airway reactivity in response to a methacholine inha-
lation challenge was determined by the impulse oscil-
lometry system (Jaeger MS-IOS; Hoechberg, Ger-
many; LAB Manager Software version 4.53.2, 2002)
using the recommended techniques of the manufac-
turer. Real-time recordings of mouth pressure and
flow signals pulsed through 5- to 20-Hz spectrum
were superimposed over tracings of tidal breathing
and displayed on a computer screen. Measurements
of resistance at 5 and 20 Hz (R5, R20, R5-R20) and reac-
tivity at 5 Hz (X) were recorded. It was agreed that
Nakajima N et al.
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CC   0.027 -0.031 -0.149 -0.104 -0.209 -0.121 -0.113  0.047
p  0.766  0.738  0.100  0.254  0.020  0.151  0.180  0.575
Health
(n = 114)
CC -0.031 -0.043 -0.065 -0.050 -0.067 -0.033 -0.008 -0.095
p  0.766  0.684  0.538  0.632  0.521  0.733  0.933  0.322
Asthma
(n = 34)
CC  0.171  0.034 -0.238 -0.174 -0.373 -0.342 -0.468  0.291
p  0.366  0.858  0.206  0.357  0.042  0.060  0.008  0.112









CC 0.086 -0.062 -0.163 -0.140 -0.225 0.040 0.077 -0.044
p 0.282  0.440  0.041  0.157  0.005 0.610 0.328  0.580
Health
(n = 133)
CC 0.054  0.050  0.018  0.036 -0.095 0.002 0.054  0.118
p 0.540  0.574  0.842  0.687  0.285 0.984 0.539  0.177
Asthma
(n = 47)
CC 0.372 -0.127 -0.408 -0.303 -0.413 0.067 0.017 -0.177
p 0.056  0.512  0.028  0.110  0.029 0.725 0.929  0.342
the value of R20 primarily demonstrates central respi-
ratory resistance, and the value of R5-R20 demon-
strates small respiratory resistance.11,18
DATA ANALYSIS
Statistical analyses and data presentation were per-
formed with the SPSS computer software package
(version 11.0; SPSS, Chicago, IL, USA). The compari-
son of each parameter among normal and asthma
subjects was performed with the Student’s t-test. Cor-
relations among lung functions and eNO levels were
made by using the Pearson correlation test. Partial
correlation was used to evaluate the effect of gender
on the correlation between lung functions and eNO
levels. Data are expressed as the mean ± SD. p values
< 0.05 were considered to be significant.
RESULTS
STUDY 1
By a histogram of height, the mean ± SD of height
was 124.5 ± 7.0 cm in the 6-10 year-old group, and
152.6 ± 11.0 cm in the 11-15 year-old group. As in our
previous report, we determined a 10 cm height range
(120-130 cm in the 6-10 year-old group, and 148-158
cm in the 11-15 year-old group) as the criteria for se-
lecting subjects for further study.19
A total of 148 younger children (120-130 cm, 8.5 ±
0.9 years) and 180 older children (148-158 cm, 12.9 ±
1.2 years) participated in Study 2 (Fig. 1). The num-
bers of normal children and asthmatic children were
114 and 34 in the younger group, respectively, and
133 and 47 in the older group, respectively (Table 1).
There were no significant differences in age, height
or weight between the normal and asthmatic chil-
dren.
STUDY 2
Results of eNO Measurements and Lung Func-
tion Tests
The eNO levels and lung function data are shown in
Table 1, 2. In both the 120-130 cm group and the 148-
158 cm group, the mean eNO level of asthmatic chil-
dren was significantly higher than that of the normal
subjects (p < 0.001, p < 0.001, Table 1).
In the 120-130 cm group, there was no difference in
the results of the lung function tests and IOS between
the asthmatic and normal subjects. However, in the
148-158 cm group, there were significant differences
between the asthmatic and normal subjects in regard
to the small airway parameters of FEV1, MMEF,50,
25HT and R5-R20.
Relationship between Lung Function Parame-
ters and eNO Level
In the 120-130 cm group, the eNO level in the total
subjects did not correlate with FVC or FEV1, but sig-
nificantly correlated with 25HT (Table 3a). When
the children were grouped according to diagnosis,
this tendency was evident in the asthmatic subjects
but not in the normal subjects.
In the 148-158 cm group, the eNO level in the total
subjects did not correlate with FVC and FEV1, but
significantly correlated with MMEF and25HT (Ta-
ble 3b). This tendency was evident in the asthmatic
eNO and Childhood Asthma
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CC -0.017 -0.064 -0.148 -0.107 -0.190 -0.110 -0.126 0.034




CC  0.046 -0.115 -0.183 -0.165 -0.259  0.018 -0.112 0.061
p  0.568  0.156  0.023  0.041  0.006  0.821  0.880 0.452
subjects but not in the normal subjects.
Relationship between IOS Parameters and eNO
In the 120-130 cm group, the eNO level in the total
subjects did not correlate with R5, R5-R20 or X5 (Table
3a). However, in the asthmatic children, small airway
respiratory resistance (R5-R20) was significantly corre-
lated with eNO (Table 3a).
In the 148-158 cm group, the eNO level in the total
subjects did not correlate with R5, R5-R20 or X5 (Table
3b). Furthermore, no correlation was observed in
when the subjects were evaluated according to the
asthma diagnosis.
The Effect of Gender and Asthma on the Rela-
tionship between Lung Function Parameters,
IOS Parameters and eNO
The partial correlation coefficient was calculated by
controlling for gender (Table 4). In the 120-130 cm
group, the eNO level in the total subjects significantly
correlated with25HT. In the 148-158 cm group, the
eNO level in the total subjects significantly correlated
with MMEF,50 and25HT (Table 4).
DISCUSSION
Exhaled NO is a good parameter for evaluating air-
way inflammation in asthma patients. A number of
previous studies have indicated that airway inflamma-
tion in asthma induces an increase in the eNO
level,5-8 moreover, the eNO level demonstrates an in-
verse correlation with FEV1 and other parameters of
lung function.20,21 However, de Gouw et al. observed
a decrease in the eNO level after bronchial provoca-
tion with histamine and adenosine-5’-monophosphate,
and this decrease significantly correlated with a de-
crease in FEV1.22 The authors concluded that the fall
in the eNO level was not caused by the procedure it-
self but was related to an acute decrease in FEV1,
thus suggesting that eNO levels are modulated by
the degree of airway obstruction. Furthermore, some
studies have reported that the eNO level is reduced
after methacholine bronchial provocation.11-13
These reports have indicated that rapid airway nar-
rowing results in a transient decrease in the eNO
level. However, it has not been precisely determined
whether chronic airway inflammation induces an in-
crease in the eNO level in normal and asthmatic chil-
dren, because many factors, particularly age and
height, have a marked effect on childhood eNO
level.14-16
We evaluated the relationships between the eNO
level, lung function and respiratory resistance in nor-
mal and asthmatic children with strictly limited age
and height. According to a previous study, the limita-
tion of age and height can minimize the confounding
effects of these factors.19 In addition, the limitation of
age can minimize the risk of infection and environ-
mental stimulation.
Our results demonstrated that the eNO level in
asthmatic children was significantly higher than that
in normal children among both the 120-130 cm (6-10
years) and the 148-158 cm (11-15 years) groups.
These results suggest that there may be a strong re-
lationship between airway inflammation and eNO
level in children. In elementary school and junior
high school, some children diagnosed with asthma
experience chronic airway inflammation, even if they
participate in everyday school activities without any
asthma attacks.
In addition, the eNO level correlated with25HT,
but not FVC and FEV1 in the younger children and
correlated with MMEF and25HT in the older chil-
dren. Among the younger children, the parameter of
small respiratory resistance, R5-R20, significantly cor-
related with the eNO level in the asthmatic group.
This tendency was not evident in the non-asthmatic
children.
The eNO level in asthmatic children was signifi-
cantly correlated with small airway parameters. Our
data suggest that eNO is mainly produced in small
airways in the stable state of childhood asthma, and
small airway lung function parameters are good indi-
cators for persistent airway inflammation. Chronic “si-
lent” small airway inflammation, which induces small
airway obstruction by smooth muscle constriction
andor mucosal edema, significantly increases the
eNO level in asthmatic children, whereas acute con-
striction of airways may induce a temporal decrease
of eNO level as described in previous reports.11-13
The effect of gender on eNO level in children has
also been discussed but is still controversial.16,23 In
this report, we did not observe any effect of gender
on the eNO level in children.
IOS is a relatively new technique for the assess-
Nakajima N et al.
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ment of airway obstruction, and is particularly useful
in patients who are not able to perform forced breath-
ing maneuvers.24,25 Vink et al. demonstrated that R
and X values showed significant changes during air-
flow obstruction by methacholine challenge.26 In the
present study, the eNO level did not correlate with an
increase in large airway resistance (R20) or X5, but
did correlate small airway resistance (R5-R20) in
younger children. This result supports our above-
mentioned conclusion, and indicates a mechanical dif-
ference in asthma control between younger and older
children.
These data suggest that eNO levels correlate with
the degree of small airway bronchoconstriction in as-
ymptomatic asthmatic children. It is possible that the
relative reduction of the ventilated airway surface by
bronchoconstriction andor mucosal edema in small
airways induces a decrease in eNO, because eNO
predominantly originates from the terminal and respi-
ratory mucosa in bronchioles.27 Small airway con-
striction andor mucosal edema, which cause a re-
duction of the luminal airway surface,28,29 may there-
fore lead to a decreased eNO level. Moreover, NO
trapping in the small airways during bronchoconstric-
tion andor mucosal edema may contribute to the re-
ductions in the eNO level.11 It is possible that eNO
production due to airway inflammation in the termi-
nal and respiratory bronchioles was more influential
than the effect of bronchoconstriction andor mu-
cosal edema.
The incidence of asthmatic children in this study
was higher than the Japanese standard. Our annual
surveys of this area in Gunma Prefecture suggest that
the incidence of asthmatic children in this area is
higher than elsewhere in Japan. The precise reason
for this phenomenon is unknown, but the incidence
of familial smoking was about twice as high as else-
where (about 70% or more), and sometimes photo-
chemical smog is present in the area. In addition,
there may have been some bias in the selection of the
subjects who knew the reason for our study and, ac-
cordingly, participated. However, our study covered a
strictly limited area, season and time, and therefore
the incidence of asthma does not directly affect our
conclusions.
Consequently, chronic “silent” small airway inflam-
mation significantly increases the eNO level in asth-
matic children. To our knowledge, this is the first
study demonstrating a relationship between small air-
way narrowing and the level of eNO while controlling
for age and height in children, and the relationship
between the level of eNO and the small airway pa-
rameter, R5-R20. Small airway lung function, which is
a good indicator of persistent airway inflammation,
should be monitored for effective control of child-
hood asthma. Furthermore, when the eNO level is
measured, the effects of both persistent and acute
bronchoconstriction andor mucosal edema in small
airways should be considered.
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